Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Wouter J. Plattel, Aurore Bergamasco, Fabrizio Trinchese, François Gavini, Nawal Bent-Ennakhil, Athanasios Zomas, Genaro Castillon, Teigna Arredondo-Bisono, Tiffany Cristarella, Yola Moride & Bastian von Tresckow. (2021) Effectiveness of brentuximab vedotin monotherapy in relapsed or refractory Hodgkin lymphoma: a systematic review and meta-analysis. Leukemia & Lymphoma 62:14, pages 3320-3332.
Read now
Read now
Erin A. Zagadailov, Shelby Corman, Viktor Chirikov, Courtney Johnson, Cynthia Macahilig, Brian Seal, Mehul R. Dalal, Paul J. Bröckelmann & Tim Illidge. (2018) Real-world effectiveness of brentuximab vedotin versus physicians’ choice chemotherapy in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantation in the United Kingdom and Germany. Leukemia & Lymphoma 59:6, pages 1413-1419.
Read now
Read now
Reyad Dada, Jamal Zekri & Rawan Al Saadi. (2016) Brentuximab vedotin in pretreated Hodgkin lymphoma patients: a systematic review and meta-analysis. Expert Opinion on Biological Therapy 16:6, pages 739-745.
Read now
Read now
Sagun Parakh, Adam C. Parslow, Hui K. Gan & Andrew M. Scott. (2016) Antibody-mediated delivery of therapeutics for cancer therapy. Expert Opinion on Drug Delivery 13:3, pages 401-419.
Read now
Read now
Massimo Martino, Moreno Festuccia, Roberta Fedele, Giuseppe Console, Michele Cimminiello, Paolo Gavarotti & Benedetto Bruno. (2016) Salvage treatment for relapsed/refractory Hodgkin lymphoma: role of allografting, brentuximab vedotin and newer agents. Expert Opinion on Biological Therapy 16:3, pages 347-364.
Read now
Read now
Vijayveer Bonthapally, Hongbo Yang, Rajeev Ayyagari, Ruo-Ding Tan, Sean Cai, Eric Wu, Ashish Gautam, Andy Chi & Dirk Huebner. (2015) Brentuximab vedotin compared with other therapies in relapsed/refractory Hodgkin lymphoma post autologous stem cell transplant: median overall survival meta-analysis. Current Medical Research and Opinion 31:7, pages 1377-1389.
Read now
Read now
Articles from other publishers (11)
Al-Anazi Khalid Ahmed, A Alshami, E Mutahar, O Abduljalil, S Kanfer, P Kaloyannidis, J Bacal, A Estanislao, I Apostolidis, N Almokhtar, M Darweesh, M Abdulbaqi, W Alenazi, Z Alshammasi, O Albanyan, A Ayyad, Z Alsomali, M Albatran, H Raslan, A Albahrani, A Alsaber, N AlMulhem, W Dridi, R Alrabeh, F Abu Rahma, F Nightingale, P Ahadai & H Alhashmi. (2023) Outcome of Outpatient Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma and Relapsed and Refractory Hodgkin Lymphoma. The Experience of King Fahad Specialist Hospital in Dammam, Saudi Arabia. Journal of Stem Cell Therapy and Transplantation 7:1, pages 003-015.
Crossref
Crossref
Paula C. Jimenez, Bianca Del B. Sahm, Paula Rezende-Teixeira, Elthon G. Ferreira, Larissa A. Guimarães & Leticia V. Costa-Lotufo. 2023. Natural Products. Natural Products
101
131
.
Rita Assi & Huda Salman. (2022) Harnessing the Potential of Chimeric Antigen Receptor T-Cell Therapy for the Treatment of T-Cell Malignancies: A Dare or Double Dare?. Cells 11:24, pages 3971.
Crossref
Crossref
Faroogh Marofi, Heshu Sulaiman Rahman, Muhammad Harun Achmad, Klunko Nataliya Sergeevna, Wanich Suksatan, Walid Kamal Abdelbasset, Maria Vladimirovna Mikhailova, Navid Shomali, Mahboubeh Yazdanifar, Ali Hassanzadeh, Majid Ahmadi, Roza Motavalli, Yashwant Pathak, Sepideh Izadi & Mostafa Jarahian. (2021) A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions. Frontiers in Immunology 12.
Crossref
Crossref
. (2021) Hodgkin Lymphoma in Children and Adolescents: Advances in Pathology, Diagnosis, and Treatment Strategies. Indian Journal of Medical and Paediatric Oncology 41:04, pages 492-509.
Crossref
Crossref
Marika Guercio, Domenico Orlando, Stefano Di Cecca, Matilde Sinibaldi, Iolanda Boffa, Simona Caruso, Zeinab Abbaszadeh, Antonio Camera, Biancamaria Cembrola, Katia Bovetti, Simona Manni, Ignazio Caruana, Roselia Ciccone, Francesca Del Bufalo, Pietro Merli, Luciana Vinti, Katia Girardi, Annalisa Ruggeri, Cristiano De Stefanis, Marco Pezzullo, Ezio Giorda, Marco Scarsella, Rita De Vito, Sabina Barresi, Andrea Ciolfi, Marco Tartaglia, Lorenzo Moretta, Franco Locatelli, Concetta Quintarelli & Biagio De Angelis. (2020) CD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T-cells. Haematologica 106:4, pages 987-999.
Crossref
Crossref
SudhirChandra Sarangi, Pranav Sopory, SoumyaSucharita Pattnaik & KH Reeta. (2020) Antibody–drug conjugates, cancer immunotherapy, and metronomic chemotherapy as novel approaches in cancer management. Indian Journal of Pharmacology 52:5, pages 402.
Crossref
Crossref
Hina Shah & Heather Jacene. 2020. Therapy Response Imaging in Oncology. Therapy Response Imaging in Oncology
177
200
.
C. Rossi & J.N. Bastie. (2019) Actualités thérapeutiques dans les lymphomes non hodgkiniens et le lymphome de Hodgkin. La Revue de Médecine Interne 40:4, pages 246-254.
Crossref
Crossref
Steven M. Bair, Lauren Strelec, Sarah J. Nagle, Sunita D. Nasta, Daniel J. Landsburg, Anthony R. Mato, Alison W. Loren, Stephen J. Schuster, Edward A. Stadtmauer & Jakub Svoboda. (2017) Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis. American Journal of Hematology 92:9, pages 879-884.
Crossref
Crossref
C?dric Rossi & Ren?-Olivier Casasnovas. (2017) Actualit?s th?rapeutiques dans le lymphome de Hodgkin. Bulletin du Cancer 104:2, pages 182-194.
Crossref
Crossref